Solid Biosciences
SLDB
SLDB
62 hedge funds and large institutions have $53M invested in Solid Biosciences in 2020 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 17 increasing their positions, 24 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
33% less capital invested
Capital invested by funds: $79.1M → $53M (-$26M)
36% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 11
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
62
Holding in Top 10
–
Calls
$9K
Puts
$3K
Top Buyers
| 1 | +$165K | |
| 2 | +$162K | |
| 3 | +$137K | |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$132K |
| 5 |
Nuveen Asset Management
Chicago,
Illinois
|
+$109K |
Top Sellers
| 1 | -$882K | |
| 2 | -$211K | |
| 3 | -$203K | |
| 4 |
AG
Artal Group
Luxembourg
|
-$183K |
| 5 |
JPMorgan Chase & Co
New York
|
-$162K |